Safety and efficacy of Vitamin D3 supplementation with Imatinib in Chronic Phase- Chronic Myeloid Leukaemia: an Exploratory Randomized Controlled Trial

Objectives The study aimed to compare early molecular response (EMR) rates at 3 months of imatinib therapy with and without vitamin D3 supplementation in patients newly diagnosed with chronic-phase chronic myeloid leukaemia (CML-CP). The secondary objective was to assess the effects of vitamin D3 on...

Full description

Saved in:
Bibliographic Details
Main Authors: Sudeep Vaniyath, Uttam Kumar Nath, Arkapal Bandyopadhyay, Sarika Palepu, Puneet Dhamija, Rituparna Chetia, Anamika Bakliwal, Debranjani Chattopadhyay, Shailendra Handu
Format: Article
Language:English
Published: BMJ Publishing Group 2023-08-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/13/8/e066361.full
Tags: Add Tag
No Tags, Be the first to tag this record!